Exercise for Kidney Failure
Trial Summary
What is the purpose of this trial?
This study will be conducted over a 3 year time period. This is a trial of an exercise intervention vs. standard of care in patients receiving chronic dialysis. The specific aims will be to determine feasibility of patient recruitment, adherence to the exercise program, and efficacy of the intervention on patient important outcomes. The exercise intervention will be delivered to randomized participants for 12 months, and consist of the prescribed use of Nordic Walking poles, online resources for exercise in the home, regular use of a pedometer to monitor progress, and regular verbal encouragement to exercise (monthly) by dialysis unit staff. Both groups will receive the same standard of care co-interventions including individualized dialysis prescriptions and health-care interactions according to practices at their centre.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on exercise for patients on dialysis, so it's best to discuss your medications with the trial team or your doctor.
What data supports the effectiveness of the treatment Exercise Prescription, Physical Activity, Exercise Therapy, Exercise Intervention for kidney failure?
Is exercise safe for people with kidney conditions?
Exercise interventions, including resistance training and physical activity, have been shown to be safe for people with kidney conditions, such as those on dialysis or who have had a kidney transplant. Studies report no adverse events like injuries or hospitalizations related to exercise, and they often improve quality of life and physical performance.16789
How is the exercise treatment for kidney failure different from other treatments?
Exercise treatment for kidney failure is unique because it focuses on improving physical functioning and quality of life through physical activity, rather than using medications or surgical interventions. It helps reduce cardiovascular risk, inflammation, and hypertension (high blood pressure), and increases strength and exercise capacity, which are not typically addressed by standard medical treatments for kidney failure.110111213
Research Team
Deborah Zimmerman, MD, MSc
Principal Investigator
Ottawa Hospital Research Institute
Eligibility Criteria
This trial is for adults with end stage kidney disease who have been on dialysis for over six months, can walk, understand English or French, and are willing to use Nordic Walking poles. It's not suitable for those with conditions like unstable angina or uncontrolled high blood pressure, a daily step count over 8000 steps, an upcoming kidney transplant from a living donor, potential renal recovery, reliance on other mobility aids they feel unsafe replacing with walking poles, or participation in another conflicting trial.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the exercise intervention for 12 months, including Nordic Walking poles, online resources, pedometer use, and monthly encouragement
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Exercise Prescription
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator